We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-0.06%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.73B
AUM Growth
-$1.64B
Cap. Flow
-$1.53B
Cap. Flow %
-56.17%
Top 10 Hldgs %
16.21%
Holding
1,904
New
449
Increased
238
Reduced
361
Closed
764

Sector Composition

Rank Sector Weight
1 Financials 19.19%
2 Healthcare 15.28%
3 Technology 12.23%
4 Consumer Discretionary 12.21%
5 Industrials 10.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMDX
1051
Insight Molecular Diagnostics
IMDX
$152M
$151K 0.01%
2,115
+1,130
+115% +$104K
DBD
1052
DELISTED
Diebold Nixdorf Incorporated
DBD
$150K 0.01%
+14,805
New +$162K
LYRA
1053
DELISTED
LYRA THERAPEUTICS INC
LYRA
$149K 0.01%
325
-295
-48% -$112K
CORR
1054
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$147K 0.01%
33,242
-26,358
-44% -$134K
ISLE
1055
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$145K 0.01%
14,700
ELA icon
1056
Envela
ELA
$557M
$144K 0.01%
34,531
-469
-1% -$1.98K
CWBR
1057
DELISTED
CohBar, Inc. Common Stock
CWBR
$144K 0.01%
4,990
-297
-6% -$10.7K
AMYT
1058
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$144K 0.01%
+11,901
New +$134K
SOL
1059
DELISTED
Emeren Group
SOL
$143K 0.01%
+21,779
New +$156K
CFB
1060
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$143K 0.01%
+11,024
New +$146K
AWH
1061
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$143K 0.01%
2,940
-1,847
-39% -$114K
PGRWU
1062
DELISTED
Progress Acquisition Corp. Units
PGRWU
$142K 0.01%
14,180
SDACU
1063
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$139K 0.01%
13,800
AXLA
1064
DELISTED
Axcella Health Inc. Common Stock
AXLA
$138K 0.01%
1,858
-703
-27% -$60.2K
SPPI
1065
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$138K 0.01%
+63,300
New +$173K
IBER.U
1066
DELISTED
Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U
$138K 0.01%
13,850
NRACU
1067
DELISTED
Northern Revival Acquisition Corporation Unit
NRACU
$137K 0.01%
13,805
ICAD
1068
DELISTED
iCAD Inc
ICAD
$136K 0.01%
+12,664
New +$165K
MSAC
1069
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$132K ﹤0.01%
13,580
ADVM
1070
DELISTED
Adverum Biotechnologies
ADVM
$131K ﹤0.01%
6,050
+2,330
+63% +$59.5K
SID icon
1071
Companhia Siderúrgica Nacional
SID
$1.49B
$131K ﹤0.01%
+24,922
New +$187K
EVOJU
1072
DELISTED
Evo Acquisition Corp. Unit
EVOJU
$131K ﹤0.01%
13,216
MACQU
1073
DELISTED
MCAP Acquisition Corporation Unit
MACQU
$129K ﹤0.01%
12,700
HTBK
1074
DELISTED
Heritage Commerce
HTBK
$126K ﹤0.01%
+10,832
New +$121K
GHACU
1075
DELISTED
Gaming & Hospitality Acquisition Corp. Unit
GHACU
$125K ﹤0.01%
12,623

Similar funds

Ergoteles's Q3 2021 Portfolio in Review

As of Q3 2021, Ergoteles held 1,904 positions worth $2.73B, down 37% from $4.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ergoteles withdrew a net $1.53B in Q3 2021, closing 764 positions and reducing 361 holdings. Its most notable exit was PRA Health Sciences, Inc., an estimated $164M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 10% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Ergoteles opened a new position in Deere & Co worth $47.6M.

  • Ergoteles's largest Q3 2021 buy was Deere & Co: 142,099 shares worth $47.6M.
  • Ergoteles added most to iShares Core S&P Total US Stock Market ETF in Q3 2021, an estimated $41.4M increase.
  • Ergoteles's biggest Q3 2021 reduction was Newmont, cutting an estimated $38.8M.
  • Ergoteles fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $164M.
  • Ergoteles's ten largest holdings make up 16% of its $2.73B portfolio in Q3 2021.
  • Ergoteles opened 449 new positions and closed 764 in Q3 2021.
  • Ergoteles's portfolio value fell 37% quarter-over-quarter to $2.73B.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.